ReShape Lifesciences Inc. entered into an Equity Distribution Agreement with Maxim Group LLC to sell up to $9,700,000 of its common stock. On June 9, 2025, the company priced a public offering of 1,054,604 shares at $2.50 per share, expecting gross proceeds of $2,636,510. Since the start of the at-the-market offering, ReShape has sold $3,642,564 worth of shares, leaving $3,420,926 available under the agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ReShape Lifesciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-057670), on June 09, 2025, and is solely responsible for the information contained therein.